Hou Jian-Wen, Hu Ze-Ying
Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, People's Republic of China.
J Inflamm Res. 2025 Jun 19;18:8119-8129. doi: 10.2147/JIR.S528332. eCollection 2025.
This study aimed to evaluate the efficacy of powder colloid in the treatment of infusion phlebitis in patients with tumors.
In this randomized controlled trial, 110 patients with grade II-III phlebitis were randomly allocated to either of two groups: the experimental group and the control group. Patients in the experimental group received powder colloid, and those in the control group were treated with a hydrocolloid. The severity of phlebitis was assessed using the Infusion Nurses Society grading criteria for phlebitis and the level of pain was assessed using a visual analog scale after 24 hours. Additional outcome measures included the duration required for pain relief, the time taken for resolution of the extent of redness and swelling, and patient satisfaction levels.
Following 24 hours of treatment, there were notable differences between the two groups in the severity of phlebitis and pain scores. Patients in the experimental group exhibited a significantly shorter time to pain relief and resolution of swelling compared to those in the control group. Additionally, patient satisfaction was significantly higher in the experimental group.
powder colloid was effective in the treatment of infusion phlebitis in patients with tumors, with treated patients demonstrating superior outcomes in terms of pain relief, resolution of swelling, and patient satisfaction.
本研究旨在评估粉末状胶体对肿瘤患者输液性静脉炎的治疗效果。
在这项随机对照试验中，110例II - III级静脉炎患者被随机分为两组：试验组和对照组。试验组患者接受粉末状胶体治疗，对照组患者采用水胶体治疗。采用静脉输液护理学会静脉炎分级标准评估静脉炎严重程度，并在24小时后使用视觉模拟评分法评估疼痛程度。其他观察指标包括疼痛缓解所需时间、红肿消退时间以及患者满意度。
治疗24小时后，两组在静脉炎严重程度和疼痛评分方面存在显著差异。试验组患者的疼痛缓解时间和肿胀消退时间明显短于对照组。此外，试验组患者的满意度显著更高。
粉末状胶体对肿瘤患者输液性静脉炎的治疗有效，接受治疗的患者在疼痛缓解、肿胀消退和患者满意度方面表现出更好的效果。
Zotero 插件
